Literature DB >> 8836603

Ganglioglioma: a clinical and pathological study of 12 cases.

G Isimbaldi1, M Sironi, G P Tonnarelli, M Roncoroni, P Declich, C Galli.   

Abstract

We report the clinico-pathological and immunohistochemical findings of 12 cases of gangliogloma that were diagnosed at Legnano Civil Hospital over a period of 10 years. The patients' age at presentation ranged from 2-69 years with a mean duration of symptoms equal to 52 months. Seizures were the most common presenting symptoms. These tumors, mainly located in the temporal lobe (5/10), displayed in 10 cases a low density appearance at CT scan. Histologically the tumors were composed of neoplastic ganglion cells mixed together with a glial component. All but one of the tumors were surgically treated: complete removal was accomplished in 8 cases and incomplete in 3 cases; 1 case was an incidental autopsy finding. Radiotherapy was administered in the incompletely removed cases. The mean follow-up period was 40.8 months, with 3 patients deceased. Our findings support the notion that ganglioglioma is a slow-growing relatively benign tumor of young adults, ubiquitous in the central nervous system with a non-specific CT scan appearance and varied histological morphology, in which immunochemical stains will confirm the diagnosis and could provide a prognostic marker.

Entities:  

Mesh:

Year:  1996        PMID: 8836603

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  8 in total

Review 1.  Malignant ganglioglioma: case report and review of literature.

Authors:  Ryan DeMarchi; Suzy Abu-Abed; David Munoz; R Loch Macdonald
Journal:  J Neurooncol       Date:  2010-06-04       Impact factor: 4.130

2.  Impact of surgery, adjuvant treatment, and other prognostic factors in the management of anaplastic ganglioglioma.

Authors:  Supriya Mallick; Rony Benson; Wineeta Melgandi; Prashanth Giridhar; G K Rath
Journal:  Childs Nerv Syst       Date:  2018-03-29       Impact factor: 1.475

3.  Postoperative radiotherapy in cranial ganglioglioma.

Authors:  Faruk Zorlu; Ugur Selek; Cem Onal; Figen Söylemezoğlu; Murat Gurkaynak
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

4.  Ganglioglioma of conus medullaris in a patient of neurofibromatosis type 1: A novel association?

Authors:  Ilangovan Vijay Sundar; Manish Jaiswal; Devendra Purohit; R S Mittal
Journal:  Asian J Neurosurg       Date:  2016 Oct-Dec

5.  Supratentorial ganglioglioma and epilepsy: postoperative seizure outcome.

Authors:  So-Hyang Im; Chun Kee Chung; Byung-Kyu Cho; Sang Kun Lee
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

6.  Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery.

Authors:  So-Hyang Im; Chun Kee Chung; Byung-Kyu Cho; Kyu-Chang Wang; In-Kyu Yu; In Chan Song; Gi Jeong Cheon; Dong Soo Lee; Na-Rae Kim; Je G Chi
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

7.  Treatment and outcomes for gangliogliomas: a single-center review of 16 patients.

Authors:  Jye Young Song; Jeong Hoon Kim; Young Hyun Cho; Chang Jin Kim; Eun Jung Lee
Journal:  Brain Tumor Res Treat       Date:  2014-10-31

8.  Short-term outcome following surgery for rare brain tumor entities in adults: a Swedish nation-wide registry-based study and comparison with SEER database.

Authors:  Jiri Bartek; Sanjay Dhawan; Erik Thurin; Ali Alattar; Sasha Gulati; Bertil Rydenhag; Roger Henriksson; Clark C Chen; Asgeir Store Jakola
Journal:  J Neurooncol       Date:  2020-05-19       Impact factor: 4.130

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.